Skip to main content
OpenTrials

Clinical trial condition

Intermittent Claudication

Explore clinical trials studying Intermittent Claudication. Study availability and eligibility vary by location and protocol.

219 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Intermittent Claudication trial results

Completed

"Unifuzol®" in Patients With Peripheral Arterial Disease

NCT03861416

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +7 more
Locations
  • Regional Clinical Hospital Barnaul, Russia
  • Kursk City Clinical Emergency Hospital Kursk, Russia
  • City Clinical Hospital № 15 named O.M. Filatov Moscow, Russia
  • Medical and sanitary Department of the Ministry of Internal Affairs of the Russian Federation in Moscow Moscow, Russia
View all 19 locations
View Trial Details
Completed

Comparison of the Ranger™ Paclitaxel-Coated PTA Balloon Catheter and Uncoated PTA Balloons in Femoropopliteal Arteries

NCT02013193

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +9 more
Locations
  • Medical University, AKH Vienna, Austria
  • CHU Caen Côte de Nacre Caen, France
  • Hopital Europeen Georges-Pompidou (HEGP) Paris, France
  • Clinique Pasteur Toulouse Toulouse, France
View Trial Details
Completed

EW-A-401 to Treat Intermittent Claudication

NCT00080392

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +7 more
Locations
  • Baptist Health System, Inc. Birmingham, Alabama, United States
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
  • University of Wisconsin Madison, Wisconsin, United States
View Trial Details
Completed

Evaluation of Cilostazol in Combination With L-Carnitine

NCT00822172

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +8 more
Locations
  • Internal Medicine Physicians Associates Phoenix, Arizona, United States
  • Tatum Ridge Internal Medicine Phoenix, Arizona, United States
  • Central Arkansas Veteran's Healthcare System Little Rock, Arkansas, United States
  • VA Palo Alto Health Care System Palo Alto, California, United States
View all 24 locations
View Trial Details
Completed

480 Biomedical Bioresorbable Scaffold System in the Treatment of de Novo Superficial Femoral Artery (SFA) Lesions

NCT01403077

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +9 more
Locations
  • The Alfred Melbourne, Australia
  • Universitäts Klinikum Graz Graz, Austria
  • Universitaet Freiburg-Bad Krozingen Freiburg im Breisgau, Germany
  • Park Hospital - Heart Center Leipzig Leipzig, Germany
View Trial Details
Completed

Treatment of SFA Lesions With 480 Biomedical STANZA™ Drug-Eluting Resorbable Scaffold (DRS) System

NCT02097082

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +7 more
Locations
  • Universitäts Klinikum Graz Graz, Austria
  • WGKK - Hanusch-Krankenhaus Vienna, Austria
  • Cardiovascular and Interventional Radiology- AKH Vienna, Austria
  • Universitäts-Herzzentrum Freiburg-Bad Krozingen GmbH Bad Krozingen, Baden-Wurttemberg, Germany
View Trial Details

Related conditions